Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Ellagic acid promotes Abeta42 fibrillization and inhibits Abeta42-induced neurotoxicity.

Feng Y, Yang SG, Du XT, Zhang X, Sun XX, Zhao M, Sun GY, Liu RT.

Biochem Biophys Res Commun. 2009 Dec 25;390(4):1250-4. doi: 10.1016/j.bbrc.2009.10.130.

PMID:
19878655
2.

The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease.

Murakami K, Masuda Y, Shirasawa T, Shimizu T, Irie K.

Geriatr Gerontol Int. 2010 Jul;10 Suppl 1:S169-79. doi: 10.1111/j.1447-0594.2010.00598.x. Review.

PMID:
20590832
3.

Protection mechanisms against Abeta42 aggregation.

Yan Y, Wang C.

Curr Alzheimer Res. 2008 Dec;5(6):548-54. Review.

PMID:
19075581
4.

Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses.

Cerpa W, Dinamarca MC, Inestrosa NC.

Curr Alzheimer Res. 2008 Jun;5(3):233-43. Review.

PMID:
18537540
5.

Role of the region 23-28 in Abeta fibril formation: insights from simulations of the monomers and dimers of Alzheimer's peptides Abeta40 and Abeta42.

Melquiond A, Dong X, Mousseau N, Derreumaux P.

Curr Alzheimer Res. 2008 Jun;5(3):244-50. Review.

PMID:
18537541
7.

Amyloid binding ligands as Alzheimer's disease therapies.

Lee VM.

Neurobiol Aging. 2002 Nov-Dec;23(6):1039-42. Review.

PMID:
12470800
8.
9.

Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.

Kirkitadze MD, Kowalska A.

Acta Biochim Pol. 2005;52(2):417-23. Review.

10.

The nucleation growth and reversibility of Amyloid-beta deposition in vivo.

Dolev I, Michaelson DM.

J Alzheimers Dis. 2006 Nov;10(2-3):291-301. Review.

PMID:
17119294
11.

Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis.

McLaurin J, Darabie AA, Morrison MR.

Ann N Y Acad Sci. 2002 Nov;977:376-83. Review.

PMID:
12480775
12.
13.

Selective modulation of Abeta42 production in Alzheimer's disease: non-steroidal anti-inflammatory drugs and beyond.

Leuchtenberger S, Beher D, Weggen S.

Curr Pharm Des. 2006;12(33):4337-55. Review.

PMID:
17105431
14.

Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms.

Kang I, Buckner T, Shay NF, Gu L, Chung S.

Adv Nutr. 2016 Sep 15;7(5):961-72. doi: 10.3945/an.116.012575. Review.

PMID:
27633111
Items per page

Supplemental Content

Support Center